Get more Radiology AI news with our free newsletter.

By signing up you content to our privacy policy


Home » news » Bot Image’s prostate MRI AI software wins new clearance

Bot Image’s prostate MRI AI software wins new clearance

7 Views


The firm had received its initial FDA clearance in 2022 for the use of ProstatID in detection and diagnosis of prostate cancer on MRI. With the new additional clearance, ProstatID can also be used in prostate cancer screening on MRI and biparametric MRI, according to the vendor.

Copyright © 2023 AuntMinnie.com



Go to publisher site for the complete article:

Read More

RadiologyAI.com

Empowering forward-thinking healthcare professionals by curating insights from pioneering companies and industry visionaries, facilitating informed decisions in the adoption and use of AI-driven solutions.

Radiology AI

For Vendors

Get Updates
  • This field is for validation purposes and should be left unchanged.

Radiology AI
Logo
Compare items
  • Total (0)
Compare